Bumetanide - ≥98%, high purity , Sodium-(potassium)-chloride cotransporter 2 inhibitor, CAS No.28395-03-1, Sodium-(potassium)-chloride cotransporter 2 inhibitor

Item Number

B129942

• Synonyms: BUMETANIDE [EP IMPURITY] | KBio1_000034 | BUMETANIDE [EP MONOGRAPH] | BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL- | BPBio1_000168 | Lopac-B-3023 | MLS000028457 | Opera_ID_1734 | Prestwick1_000276 | 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Potent, selective Na + /2Cl - /K + cotransporter inhibitor. Shows 40-fold greater potency than furosemide ( Asc 314 ). Shows diuretic and anticonvulsant effects in vivo.
• Storage Temp: Store at 2-8°C
• Shipped In: Wet ice
• Grade: Moligand™
• Action Type: AGONIST, INHIBITOR
• Mechanism of action: Sodium-(potassium)-chloride cotransporter 2 inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Bumetanide
Inhibitor of Na+/K+/Cl- cotransporter.